Sign in

CIK 0001600620

  • Large accelerated filer

Aurinia Pharmaceuticals Inc.

Sign in to watch
Ticker
AUPH
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
Operating
EIN
981231763
Phone
+1 250-744-2487
Business address
#140, 14315 - 118 AVENUE, EDMONTON, Alberta, Canada, T5L 4S6
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$735,889
in 3 filings

Net −$735,889. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Robertson Stephen P. −$736K Chief Legal Officer sold 7% of stake
Date Insider Transaction Shares Price Value Owned after
2022-03-02 Colao Massimilano Chief Commercial Officer Grant or award · Restricted Stock Unit +104,080 104,080
2022-03-02 Colao Massimilano Chief Commercial Officer Grant or award · Stock Option (right to buy) +178,063 178,063
2022-03-02 Greenleaf Peter Chief Executive Officer Grant or award +28,300 42,035
2022-03-02 Greenleaf Peter Chief Executive Officer Sale −9,068 $12.01 $109K 32,967
2022-03-02 Greenleaf Peter Chief Executive Officer Grant or award · Restricted Stock Unit +312,240 312,240
2022-03-02 Greenleaf Peter Chief Executive Officer Grant or award · Stock Option (right to buy) +534,188 534,188
2022-03-02 Robertson Stephen P. EVP, General Counsel Grant or award +8,500 11,682
2022-03-02 Robertson Stephen P. EVP, General Counsel Grant or award · Restricted Stock Unit +104,080 104,080
2022-03-02 Robertson Stephen P. EVP, General Counsel Grant or award · Stock Option (right to buy) +178,063 178,063
2022-03-02 Solomons Neil Chief Medical Officer Grant or award +8,500 95,799
2022-03-02 Solomons Neil Chief Medical Officer Sale −4,846 $12.01 $58K 90,953
2022-03-02 Solomons Neil Chief Medical Officer Grant or award · Restricted Stock Unit +72,856 72,856
2022-03-02 Solomons Neil Chief Medical Officer Grant or award · Stock Option (right to buy) +124,644 124,644
2022-03-02 Huizinga Robert Bindert EVP of Research Grant or award +8,500 74,228
2022-03-02 Huizinga Robert Bindert EVP of Research Sale −4,849 $12.01 $58K 69,379
2022-03-02 Huizinga Robert Bindert EVP of Research Grant or award · Restricted Stock Unit +62,448 62,448
2022-03-02 Huizinga Robert Bindert EVP of Research Grant or award · Stock Option (right to buy) +106,838 106,838
2022-01-03 Hagan Joseph P Director Option exercise +40,000 $5.08 $203K 43,500
2022-01-03 Hagan Joseph P Director Sale −39,366 $22.58 $889K 4,134
2022-01-03 Hagan Joseph P Director Sale −634 $23.29 $15K 3,500

Page 12 of 18 · 345 trades